GlassScriptPhysician profile
David P Lloyd
NPI 1003816711
$3,562.06
in general payments reported to CMS, 2019-2025
23 companies · $523 in 2025
The $523 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,715 · 2020: $212 · 2021: $49.69 · 2022: $413 · 2023: $474 · 2024: $176 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $1,526.55 | 2019 | |
| Medtronic, INC. | $451.38 | 2022-2025 | Venaseal, Closurefast |
| Tactile Systems Technology INC | $232.88 | 2025 | Flexitouch Plus, Nimbl |
| Amgen INC. | $188.99 | 2022-2023 | Kyprolis |
| Atricure, INC. | $153.61 | 2023-2024 | |
| Astellas Pharma US INC | $124.03 | 2019 | |
| Lemaitre Vascular, INC. | $123.31 | 2020-2023 | Artegraft Vascular Graft |
| W. L. Gore & Associates, INC. | $117.24 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Endologix LLC | $111.38 | 2020 | |
| Medical Device Business Services, INC. | $108.47 | 2022 | |
| Cook Medical LLC | $62.31 | 2019-2021 | |
| Bsn Medical INC | $50.69 | 2025 | |
| Abbott Laboratories | $44.05 | 2022 | |
| Getinge USA Sales, LLC | $39.88 | 2023 | Cardioroot |
| Janssen Biotech, INC. | $37.42 | 2021-2023 | Tecvayli |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.91 | 2019-2023 | Evarrest, Prolene, Ethicon |
| Zimmer Biomet Holdings, INC. | $28.10 | 2022-2024 | Sternalock Blu System |
| Silk Road Medical, INC. | $26.48 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Celgene Corporation | $24.37 | 2021 | |
| Terumo Medical Corporation | $23.64 | 2020 | |
| Genentech USA, INC. | $22.29 | 2024 | Alecensa, Tecentriq, Rozlytrek |
| Janssen Pharmaceuticals, INC | $21.99 | 2022 | |
| Edwards Lifesciences Corporation | $14.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.